Decreased CSF Aβ42 correlates with brain atrophy in cognitively normal elderly

OBJECTIVES: In order for therapies for Alzheimer's disease (AD) to have the greatest impact, it will likely be necessary to treat individuals in the “preclinical” (presymptomatic) stage. Fluid and neuroimaging measures are being explored as possible biomarkers of AD pathology that could aid in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Fagan, Anne M., Head, Denise, Shah, Aarti R., Marcus, Daniel, Mintun, Mark, Morris, John C., Holtzman, David M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2763631/
https://ncbi.nlm.nih.gov/pubmed/19260027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21559
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller